Ayurvedic Management of Drug-induced Liver Injury

Abstract Drug-induced liver injury (DILI) is an adverse toxic reaction to drugs and remains an uncommon clinical condition, with an estimated incidence of 14–19 cases per 100,000 population and accounting for less than 1% of acute liver injury. A 36-year-old married male presented with weakness, yellowish discoloration of the body, fatigue, mild shortness of breath, decreased appetite, irritability, and reddish-yellow urine and stools. He was diagnosed with DILI, with markedly elevated laboratory values including total bilirubin of 9.7 mg/dL, AST of 161 IU/mL, and ALT of 713 IU/mL. The patient was treated with Ayurvedic Shamana medicines possessing Pittahara, Rasaprasadana , and Raktaprasadana properties, with ingredients known for hepatoprotective activity. Significant improvement was observed after treatment, with total bilirubin reducing to 0.7 mg/dL, AST to 34 U/L, and ALT to 48 U/L, along with marked symptomatic relief. Amidst concerns regarding Ayurvedic medicines and liver injury, this case highlights the successful management of acute DILI with ascites through Ayurveda. Further large-scale studies with standardized protocols are needed to validate this therapeutic approach scientifically.

Authors

Institutions

Publication Details

Journal
Journal of Ayurvedic and Herbal Medicine
Published
2026-04-22
DOI
https://doi.org/10.4103/jahm.jahm_77_25
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ayurvedic Management of Drug-induced Liver Injury

Anju S. Raj, Stanzin Angmo, Anjali Kaushik, Ramakant Yadava et al.
Journal of Ayurvedic and Herbal Medicine
Drug-Induced Hepatotoxicity and Protection
article

Ayurvedic Management of Drug-induced Liver Injury

Anju S. Raj, Stanzin Angmo, Anjali Kaushik, Ramakant Yadava, P. Arshath Jyothi
article en

Abstract

Abstract Drug-induced liver injury (DILI) is an adverse toxic reaction to drugs and remains an uncommon clinical condition, with an estimated incidence of 14–19 cases per 100,000 population and accounting for less than 1% of acute liver injury. A 36-year-old married male presented with weakness, yellowish discoloration of the body, fatigue, mild shortness of breath, decreased appetite, irritability, and reddish-yellow urine and stools. He was diagnosed with DILI, with markedly elevated laboratory values including total bilirubin of 9.7 mg/dL, AST of 161 IU/mL, and ALT of 713 IU/mL. The patient was treated with Ayurvedic Shamana medicines possessing Pittahara, Rasaprasadana , and Raktaprasadana properties, with ingredients known for hepatoprotective activity. Significant improvement was observed after treatment, with total bilirubin reducing to 0.7 mg/dL, AST to 34 U/L, and ALT to 48 U/L, along with marked symptomatic relief. Amidst concerns regarding Ayurvedic medicines and liver injury, this case highlights the successful management of acute DILI with ascites through Ayurveda. Further large-scale studies with standardized protocols are needed to validate this therapeutic approach scientifically.

Journal of Ayurvedic and Herbal Medicine
National Institute of Ayurveda (IN)
Good health and well-being
Openalex Percentile: Top 6%
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.